Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1186/s43043-021-00064-5
Published Online: 2021-07-05
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ali, Mustafa
Hira, Aruna Kumari
Jawaid, Haris
Zakaria, Faiza
Somjee, Zehra
Text and Data Mining valid from 2021-07-05
Version of Record valid from 2021-07-05
Article History
Received: 23 March 2021
Accepted: 11 June 2021
First Online: 5 July 2021
Declarations
:
: Not applicable.